The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

Y. Refaeli, David Levy, D. B. Weiner

Research output: Contribution to journalArticle

Abstract

The vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 15- kDa virion-associated protein that functions as a regulator of cellular processes linked to the HIV life cycle. We report the interaction of a 41- kDa cytosolic viral protein R interacting protein 1 (Rip-1) with Vpr in vitro. Rip-1 displays a wide tissue distribution, including relevant targets of HIV infection. Vpr protein induced nuclear translocation of Rip-1, as did glucocorticoid receptor (GR)-II-stimulating steroids. Importantly, Vpr and Rip-1 coimmunoprecipitated with the human GR as part of an activated receptor complex. Vpr complementation of a vpr mutant virus was also mimicked by GR- II-stimulating steroids. Vpr and GR-II actions were inhibited by mifepristone, a GR-II pathway inhibitor. Together these data directly link the activity of the vpr gene product to the glucocorticoid steroid pathway and provide a biochemical mechanism for the cellular and viral activity of Vpr, as well as suggest that a unique class of antivirals, which includes mifepristone (RU486), may influence HIV-1 replication.

Original languageEnglish (US)
Pages (from-to)3621-3625
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number8
StatePublished - 1995

Fingerprint

Human Immunodeficiency Virus vpr Gene Products
vpr Gene Products
Glucocorticoid Receptors
HIV-1
Mifepristone
Steroids
Nuclear Receptor Coactivator 2
Proteins
vpr Genes
Tissue Distribution
Virus Replication
Life Cycle Stages
Virion
Glucocorticoids
HIV Infections
Antiviral Agents
HIV
Viruses

ASJC Scopus subject areas

  • General
  • Genetics

Cite this

The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. / Refaeli, Y.; Levy, David; Weiner, D. B.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 8, 1995, p. 3621-3625.

Research output: Contribution to journalArticle

@article{00e1308ce58e4f07b1e0e6814d0e1de6,
title = "The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product",
abstract = "The vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 15- kDa virion-associated protein that functions as a regulator of cellular processes linked to the HIV life cycle. We report the interaction of a 41- kDa cytosolic viral protein R interacting protein 1 (Rip-1) with Vpr in vitro. Rip-1 displays a wide tissue distribution, including relevant targets of HIV infection. Vpr protein induced nuclear translocation of Rip-1, as did glucocorticoid receptor (GR)-II-stimulating steroids. Importantly, Vpr and Rip-1 coimmunoprecipitated with the human GR as part of an activated receptor complex. Vpr complementation of a vpr mutant virus was also mimicked by GR- II-stimulating steroids. Vpr and GR-II actions were inhibited by mifepristone, a GR-II pathway inhibitor. Together these data directly link the activity of the vpr gene product to the glucocorticoid steroid pathway and provide a biochemical mechanism for the cellular and viral activity of Vpr, as well as suggest that a unique class of antivirals, which includes mifepristone (RU486), may influence HIV-1 replication.",
author = "Y. Refaeli and David Levy and Weiner, {D. B.}",
year = "1995",
language = "English (US)",
volume = "92",
pages = "3621--3625",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "8",

}

TY - JOUR

T1 - The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product

AU - Refaeli, Y.

AU - Levy, David

AU - Weiner, D. B.

PY - 1995

Y1 - 1995

N2 - The vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 15- kDa virion-associated protein that functions as a regulator of cellular processes linked to the HIV life cycle. We report the interaction of a 41- kDa cytosolic viral protein R interacting protein 1 (Rip-1) with Vpr in vitro. Rip-1 displays a wide tissue distribution, including relevant targets of HIV infection. Vpr protein induced nuclear translocation of Rip-1, as did glucocorticoid receptor (GR)-II-stimulating steroids. Importantly, Vpr and Rip-1 coimmunoprecipitated with the human GR as part of an activated receptor complex. Vpr complementation of a vpr mutant virus was also mimicked by GR- II-stimulating steroids. Vpr and GR-II actions were inhibited by mifepristone, a GR-II pathway inhibitor. Together these data directly link the activity of the vpr gene product to the glucocorticoid steroid pathway and provide a biochemical mechanism for the cellular and viral activity of Vpr, as well as suggest that a unique class of antivirals, which includes mifepristone (RU486), may influence HIV-1 replication.

AB - The vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 15- kDa virion-associated protein that functions as a regulator of cellular processes linked to the HIV life cycle. We report the interaction of a 41- kDa cytosolic viral protein R interacting protein 1 (Rip-1) with Vpr in vitro. Rip-1 displays a wide tissue distribution, including relevant targets of HIV infection. Vpr protein induced nuclear translocation of Rip-1, as did glucocorticoid receptor (GR)-II-stimulating steroids. Importantly, Vpr and Rip-1 coimmunoprecipitated with the human GR as part of an activated receptor complex. Vpr complementation of a vpr mutant virus was also mimicked by GR- II-stimulating steroids. Vpr and GR-II actions were inhibited by mifepristone, a GR-II pathway inhibitor. Together these data directly link the activity of the vpr gene product to the glucocorticoid steroid pathway and provide a biochemical mechanism for the cellular and viral activity of Vpr, as well as suggest that a unique class of antivirals, which includes mifepristone (RU486), may influence HIV-1 replication.

UR - http://www.scopus.com/inward/record.url?scp=0028967421&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028967421&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 3621

EP - 3625

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 8

ER -